Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
39
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Simonian Nancy A | President and CEO | 53 | $0 | $46.4K | 2024-12-02 |
| Quirk Gerald E | Chief Legal Officer | 21 | $0 | $10.3K | 2024-11-19 |
| Haas Jason | Chief Financial Officer | 24 | $161.5K | $28.9K | 2024-11-18 |
| Chee Conley | President & CEO | 26 | $161.0K | $27.0K | 2024-11-18 |
| Stephens Kristin | Chief Development Officer | 22 | $0 | $7.9K | 2024-11-18 |
| Roth David | Chief Medical Officer | 33 | $0 | $139.9K | 2024-11-18 |
| Young Richard A | Director | 37 | $0 | $1.35M | 2024-09-16 |
| AKKARAJU SRINIVAS | Director | 38 | $10.99M | $3.86M | 2024-09-16 |
| Eckhardt Sue Gail | Director | 9 | $0 | $0 | 2024-06-05 |
| OH ANDREW M. | Director | 6 | $0 | $0 | 2024-06-05 |
| Dunsire Deborah | Director | 10 | $0 | $0 | 2024-06-05 |
| Fanucci Marsha | Director | 14 | $0 | $0 | 2024-06-05 |
| TYSON TIMOTHY | Director | 19 | $106.0K | $0 | 2024-06-05 |
| WIRTH PETER | Director | 12 | $0 | $0 | 2024-06-05 |
| Alles Mark J | Director | 11 | $88.6K | $0 | 2023-09-16 |
| Olson Eric R | Chief Scientific Officer | 36 | $0 | $619.0K | 2023-07-17 |
| Nashat Amir | Director, 10% Owner | 14 | $5.00M | $0 | 2022-06-01 |
| SHARP PHILLIP A | Director | 16 | $0 | $0 | 2022-06-01 |
| Ferra Joseph J Jr | Chief Financial Officer | 6 | $0 | $0 | 2021-02-17 |
| Springhorn Jeremy P. | Chief Business Officer | 9 | $235.8K | $0 | 2021-02-17 |
| ARCH Venture Partners VII, L.P. | 10% Owner | 3 | $0 | $489.5K | 2019-07-17 |
| Shaw Alice Tsang | Director | 1 | $0 | $0 | 2019-06-11 |
| BONNEY MICHAEL W | Director | 2 | $0 | $0 | 2019-06-11 |
| SATO VICKI L | Director | 5 | $0 | $0 | 2019-06-11 |
| ARCH Venture Fund VII, L.P. | 10% Owner | 7 | $0 | $2.43M | 2019-03-14 |
| DeSimone Colleen Elizabeth | Principal Accounting Officer | 3 | $0 | $8.8K | 2017-10-23 |
| KANIA EDWIN M JR | 10% Owner | 3 | $0 | $0 | 2017-08-17 |
| Patel Sanj K | Director | 3 | $0 | $0 | 2017-06-08 |
| NELSEN ROBERT | Director, 10% Owner | 12 | $5.00M | $0 | 2017-06-08 |
| Kuvalanka Kyle D. | Chief Operating Officer | 1 | $0 | $0 | 2017-02-10 |
| Bancel Stephane | Director | 3 | $0 | $0 | 2016-09-15 |
| WuXi PharmTech Healthcare Fund I L.P. | 10% Owner | 8 | $0 | $0 | 2016-07-06 |
| Green Jeremy | 10% Owner | 14 | $5.41M | $0 | 2016-07-06 |
| WuXi Healthcare Ventures II, L.P. | 10% Owner | 2 | $0 | $0 | 2016-07-06 |
| Flagship VentureLabs IV, LLC | 10% Owner | 18 | $5.00M | $0 | 2016-07-06 |
| Polaris Partners VII, L.P. | 10% Owner | 6 | $5.00M | $0 | 2016-07-06 |
| Deerfield Mgmt III, L.P. | 10% Owner | 6 | $5.00M | $0 | 2016-07-06 |
| Aisling Capital Partners III LLC | 10% Owner | 3 | $5.00M | $0 | 2016-07-06 |
| BYBEE CLINTON | 10% Owner | 9 | $5.00M | $0 | 2016-07-06 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Simonian Nancy A | Director | S Sale | 2024-12-02 | 2024-12-04 | 37,070 | $0.27 | $10.0K | 4,000 | SEC↗ |
| Simonian Nancy A | Director | S Sale | 2024-11-25 | 2024-11-27 | 134,713 | $0.27 | $36.4K | 41,070 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | S Sale | 2024-11-19 | 2024-11-20 | 46,657 | $0.22 | $10.3K | 0 | SEC↗ |
| Haas Jason | Chief Financial Officer | S Sale | 2024-11-18 | 2024-11-20 | 137,803 | $0.21 | $28.9K | 0 | SEC↗ |
| Chee Conley | President & CEO | S Sale | 2024-11-18 | 2024-11-20 | 134,797 | $0.20 | $27.0K | 0 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2024-11-18 | 2024-11-20 | 12,099 | $0.20 | $2.4K | 0 | SEC↗ |
| Stephens Kristin | Chief Development Officer | S Sale | 2024-11-18 | 2024-11-20 | 36,133 | $0.22 | $7.9K | 0 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise deriv | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Chee Conley | President & CEO | M Exercise deriv | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 0 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise deriv | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 0 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise deriv | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 0 | SEC↗ |
| Simonian Nancy A | Director | M Exercise deriv | 2024-10-31 | 2024-11-04 | 40,125 | — | $0 | 0 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 42,237 | SEC↗ |
| Stephens Kristin | Chief Development Officer | F Tax w/h | 2024-10-31 | 2024-11-04 | 6,104 | $2.09 | $12.8K | 36,133 | SEC↗ |
| Chee Conley | President & CEO | F Tax w/h | 2024-10-31 | 2024-11-04 | 8,707 | $2.09 | $18.2K | 130,797 | SEC↗ |
| Chee Conley | President & CEO | M Exercise | 2024-10-31 | 2024-11-04 | 17,000 | — | $0 | 139,504 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 143,427 | SEC↗ |
| Haas Jason | Chief Financial Officer | F Tax w/h | 2024-10-31 | 2024-11-04 | 5,624 | $2.09 | $11.8K | 137,803 | SEC↗ |
| Roth David | Chief Medical Officer | F Tax w/h | 2024-10-31 | 2024-11-04 | 6,776 | $2.09 | $14.2K | 12,099 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise | 2024-10-31 | 2024-11-04 | 18,875 | — | $0 | 18,875 | SEC↗ |
| Simonian Nancy A | Director | M Exercise | 2024-10-31 | 2024-11-04 | 40,125 | — | $0 | 175,783 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise deriv | 2024-09-30 | 2024-10-02 | 10,000 | — | $0 | 20,000 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | F Tax w/h | 2024-09-30 | 2024-10-02 | 3,100 | $2.10 | $6.5K | 46,657 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise | 2024-09-30 | 2024-10-02 | 10,000 | — | $0 | 49,757 | SEC↗ |
| Young Richard A | Director | M Exercise deriv | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 2,667 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise deriv | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 2,667 | SEC↗ |
| Young Richard A | Director | M Exercise | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 10,667 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 9,333 | SEC↗ |
| Haas Jason | Chief Financial Officer | P Buy | 2024-09-12 | 2024-09-12 | 45,344 | $1.68 | $76.2K | 124,552 | SEC↗ |
| Haas Jason | Chief Financial Officer | P Buy | 2024-09-11 | 2024-09-12 | 19,293 | $1.58 | $30.5K | 79,208 | SEC↗ |
| Chee Conley | President & CEO | P Buy | 2024-09-11 | 2024-09-12 | 50,000 | $1.71 | $85.5K | 122,504 | SEC↗ |
| Haas Jason | Chief Financial Officer | P Buy | 2024-09-10 | 2024-09-12 | 35,363 | $1.55 | $54.8K | 59,915 | SEC↗ |
| Chee Conley | President & CEO | P Buy | 2024-09-10 | 2024-09-12 | 50,000 | $1.51 | $75.5K | 72,504 | SEC↗ |
| Young Richard A | Director | S Sale | 2024-06-28 | 2024-07-02 | 34,837 | $5.12 | $178.4K | 8,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Simonian Nancy A | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| OH ANDREW M. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Simonian Nancy A | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 135,658 | SEC↗ |
| OH ANDREW M. | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| Young Richard A | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 42,837 | SEC↗ |
| WIRTH PETER | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| Fanucci Marsha | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 16,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 33,189 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 0 | SEC↗ |
| Dunsire Deborah | Director | M Exercise deriv | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 6,666 | SEC↗ |
| Dunsire Deborah | Director | M Exercise | 2024-06-01 | 2024-06-04 | 4,000 | — | $0 | 12,000 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2024-04-03 | 2024-04-05 | 10,451 | $4.95 | $51.7K | 0 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2024-04-02 | 2024-04-02 | 150 | $4.98 | $747 | 10,451 | SEC↗ |
| Chee Conley | President & CEO | F Tax w/h | 2024-04-01 | 2024-04-02 | 3,500 | $5.12 | $17.9K | 22,504 | SEC↗ |
| Haas Jason | Chief Financial Officer | F Tax w/h | 2024-04-01 | 2024-04-02 | 4,732 | $5.12 | $24.2K | 24,552 | SEC↗ |
| Roth David | Chief Medical Officer | F Tax w/h | 2024-04-01 | 2024-04-02 | 4,732 | $5.12 | $24.2K | 10,601 | SEC↗ |
| Simonian Nancy A | Director | F Tax w/h | 2024-04-01 | 2024-04-02 | 14,052 | $5.12 | $71.9K | 131,658 | SEC↗ |
| Stephens Kristin | Chief Development Officer | F Tax w/h | 2024-04-01 | 2024-04-02 | 4,218 | $5.12 | $21.6K | 25,237 | SEC↗ |
| Chee Conley | President & CEO | M Exercise deriv | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 23,334 | SEC↗ |
| Chee Conley | President & CEO | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 26,667 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 26,667 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Simonian Nancy A | Director | M Exercise deriv | 2024-03-31 | 2024-04-02 | 6,000 | — | $0 | 12,000 | SEC↗ |
| Simonian Nancy A | Director | M Exercise deriv | 2024-03-31 | 2024-04-02 | 39,566 | — | $0 | 79,134 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 23,334 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise deriv | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Chee Conley | President & CEO | M Exercise | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 26,004 | SEC↗ |
| Chee Conley | President & CEO | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 14,338 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 15,951 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 29,284 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise | 2024-03-31 | 2024-04-02 | 13,333 | — | $0 | 15,333 | SEC↗ |
| Simonian Nancy A | Director | M Exercise | 2024-03-31 | 2024-04-02 | 39,566 | — | $0 | 145,710 | SEC↗ |
| Simonian Nancy A | Director | M Exercise | 2024-03-31 | 2024-04-02 | 6,000 | — | $0 | 106,144 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise | 2024-03-31 | 2024-04-02 | 11,666 | — | $0 | 29,455 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise | 2024-03-31 | 2024-04-02 | 2,000 | — | $0 | 17,789 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | F Tax w/h | 2024-03-28 | 2024-04-02 | 7,046 | $5.59 | $39.4K | 39,757 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise deriv | 2024-03-27 | 2024-04-02 | 22,500 | — | $0 | 0 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise | 2024-03-27 | 2024-04-02 | 22,500 | — | $0 | 46,803 | SEC↗ |
| AKKARAJU SRINIVAS | Director | P Buy | 2023-12-21 | 2023-12-26 | 904,977 | $4.42 | $4.00M | 1,786,427 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2023-12-12 | 2023-12-14 | 6,287 | $4.95 | $31.1K | 0 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2023-12-06 | 2023-12-08 | 6,287 | $3.95 | $24.8K | 6,287 | SEC↗ |
| Chee Conley | President & CEO | A Award deriv | 2023-12-02 | 2023-12-05 | 86,000 | — | $0 | 86,000 | SEC↗ |
| Simonian Nancy A | Director | D To issuer deriv | 2023-12-01 | 2023-12-05 | 28,001 | — | $0 | 0 | SEC↗ |
| Simonian Nancy A | Director | D To issuer deriv | 2023-12-01 | 2023-12-05 | 29,399 | — | $0 | 0 | SEC↗ |
| Simonian Nancy A | Director | D To issuer deriv | 2023-12-01 | 2023-12-05 | 30,399 | — | $0 | 0 | SEC↗ |
| Simonian Nancy A | Director | D To issuer deriv | 2023-12-01 | 2023-12-05 | 17,499 | — | $0 | 0 | SEC↗ |
| Simonian Nancy A | Director | D To issuer deriv | 2023-12-01 | 2023-12-05 | 7,500 | — | $0 | 0 | SEC↗ |
| Chee Conley | Chief Commercial Officer | F Tax w/h | 2023-11-01 | 2023-11-02 | 6,004 | $2.22 | $13.3K | 12,338 | SEC↗ |
| Stephens Kristin | Chief Development Officer | F Tax w/h | 2023-11-01 | 2023-11-02 | 5,676 | $2.22 | $12.6K | 15,789 | SEC↗ |
| Roth David | Chief Medical Officer | F Tax w/h | 2023-11-01 | 2023-11-02 | 6,301 | $2.22 | $14.0K | 12,574 | SEC↗ |
| Haas Jason | Chief Financial Officer | F Tax w/h | 2023-11-01 | 2023-11-02 | 6,301 | $2.22 | $14.0K | 13,951 | SEC↗ |
| Simonian Nancy A | President & CEO | F Tax w/h | 2023-11-01 | 2023-11-02 | 13,401 | $2.22 | $29.8K | 100,144 | SEC↗ |
| Chee Conley | Chief Commercial Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 17,000 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 18,875 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise deriv | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 18,875 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise deriv | 2023-10-31 | 2023-11-02 | 40,125 | — | $0 | 40,125 | SEC↗ |
| Chee Conley | Chief Commercial Officer | M Exercise | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 18,342 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise | 2023-10-31 | 2023-11-02 | 17,000 | — | $0 | 21,465 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 18,875 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise | 2023-10-31 | 2023-11-02 | 18,875 | — | $0 | 20,252 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise | 2023-10-31 | 2023-11-02 | 40,125 | — | $0 | 113,545 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | F Tax w/h | 2023-10-19 | 2023-10-20 | 6,897 | $2.10 | $14.5K | 24,303 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise deriv | 2023-10-11 | 2023-10-20 | 22,500 | — | $0 | 22,500 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | M Exercise | 2023-10-11 | 2023-10-20 | 22,500 | — | $0 | 31,200 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise deriv | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 5,334 | SEC↗ |
| Alles Mark J | Director | M Exercise deriv | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 5,334 | SEC↗ |
| Young Richard A | Director | M Exercise deriv | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 5,334 | SEC↗ |
| AKKARAJU SRINIVAS | Director | M Exercise | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 2,666 | SEC↗ |
| Alles Mark J | Director | M Exercise | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 3,666 | SEC↗ |
| Young Richard A | Director | M Exercise | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 38,837 | SEC↗ |
| Quirk Gerald E | Chief Legal & Compliance Off | A Award deriv | 2023-09-12 | 2023-09-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Roth David | Chief Medical Officer | S Sale | 2023-07-31 | 2023-08-02 | 7,348 | $3.95 | $29.0K | 0 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2023-07-17 | 2023-07-18 | 689 | $3.50 | $2.4K | 6,661 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| OH ANDREW M. | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| Fanucci Marsha | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| OH ANDREW M. | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 29,189 | SEC↗ |
| WIRTH PETER | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| Young Richard A | Director | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 36,171 | SEC↗ |
| Simonian Nancy A | President & CEO | F Tax w/h | 2023-04-03 | 2023-04-04 | 1,852 | $2.58 | $4.8K | 73,420 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 7,350 | SEC↗ |
| Stephens Kristin | Chief Development Officer | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 4,465 | SEC↗ |
| Roth David | Chief Medical Officer | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 7,348 | SEC↗ |
| Chee Conley | Chief Commercial Officer | F Tax w/h | 2023-04-03 | 2023-04-04 | 658 | $2.58 | $1.7K | 1,342 | SEC↗ |
| Haas Jason | Chief Financial Officer | F Tax w/h | 2023-04-03 | 2023-04-04 | 623 | $2.58 | $1.6K | 1,377 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise deriv | 2023-03-31 | 2023-04-04 | 6,000 | — | $0 | 18,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Chee Conley | Chief Commercial Officer | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise deriv | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise | 2023-03-31 | 2023-04-04 | 6,000 | — | $0 | 75,272 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 7,973 | SEC↗ |
| Stephens Kristin | Chief Development Officer | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 5,088 | SEC↗ |
| Roth David | Chief Medical Officer | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 7,971 | SEC↗ |
| Chee Conley | Chief Commercial Officer | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | M Exercise | 2023-03-31 | 2023-04-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2023-02-16 | 2023-02-21 | 118,700 | — | $0 | 118,700 | SEC↗ |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2023-02-16 | 2023-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Quirk Gerald E | Chief Legal Officer | A Award deriv | 2022-10-11 | 2022-10-13 | 45,000 | — | $0 | 45,000 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2022-10-06 | 2022-10-11 | 80,250 | — | $0 | 80,250 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2022-10-06 | 2022-10-11 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 37,750 | — | $0 | 37,750 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 49,750 | — | $0 | 49,750 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 37,750 | — | $0 | 37,750 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 49,750 | — | $0 | 49,750 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| Chief Commercial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ | |
| Chief Commercial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ | |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 44,500 | — | $0 | 44,500 | SEC↗ |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2022-10-06 | 2022-10-11 | 34,000 | — | $0 | 34,000 | SEC↗ |
| TYSON TIMOTHY | Director | P Buy | 2022-09-30 | 2022-10-03 | 14,000 | $6.37 | $89.2K | 24,932 | SEC↗ |
| TYSON TIMOTHY | Director | P Buy | 2022-09-29 | 2022-10-03 | 2,932 | $5.72 | $16.8K | 10,932 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 691,489 | — | $0 | 691,489 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 3,856 | — | $0 | 3,856 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 3,856 | — | $0 | 3,856 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 2,848 | — | $0 | 2,848 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 2,191 | — | $0 | 2,191 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 2,191 | — | $0 | 2,191 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 3,286 | — | $0 | 3,286 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 1,094 | — | $0 | 1,094 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 2,232 | — | $0 | 2,232 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2023-04-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award | 2022-09-16 | 2023-04-20 | 691,489 | — | $0 | 881,450 | SEC↗ |
| TYSON TIMOTHY | Director | A Award | 2022-09-16 | 2023-04-20 | 257 | — | $0 | 8,257 | SEC↗ |
| TYSON TIMOTHY | Director | A Award | 2022-09-16 | 2023-04-20 | 8,000 | — | $0 | 8,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OH ANDREW M. | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Dunsire Deborah | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Fanucci Marsha | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OH ANDREW M. | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| TYSON TIMOTHY | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| WIRTH PETER | Director | A Award | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Nashat Amir | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SHARP PHILLIP A | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Simonian Nancy A | President & CEO | F Tax w/h | 2022-04-01 | 2022-04-04 | 58,883 | $1.12 | $65.9K | 692,723 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | F Tax w/h | 2022-04-01 | 2022-04-04 | 27,266 | $1.12 | $30.5K | 59,734 | SEC↗ |
| Roth David | Chief Medical Officer | F Tax w/h | 2022-04-01 | 2022-04-04 | 27,281 | $1.12 | $30.6K | 59,719 | SEC↗ |
| Stephens Kristin | Chief Development Officer | F Tax w/h | 2022-04-01 | 2022-04-04 | 14,115 | $1.12 | $15.8K | 30,885 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2022-02-15 | 2022-02-17 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2022-02-15 | 2022-02-17 | 375,000 | — | $0 | 375,000 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2022-02-15 | 2022-02-17 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Stephens Kristin | Chief Development Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2022-02-15 | 2022-02-17 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2022-01-05 | 2022-01-06 | 2,208 | $3.47 | $7.7K | 0 | SEC↗ |
| Haas Jason | Chief Financial Officer | A Award deriv | 2021-10-12 | 2021-10-13 | 750,000 | — | $0 | 750,000 | SEC↗ |
| Chee Conley | Chief Commercial Officer | A Award deriv | 2021-09-27 | 2021-09-28 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Dunsire Deborah | Director | A Award deriv | 2021-09-09 | 2021-09-10 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2021-07-01 | 2021-07-01 | 1,164 | $5.55 | $6.5K | 0 | SEC↗ |
| Alles Mark J | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Fanucci Marsha | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Nashat Amir | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SHARP PHILLIP A | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| WIRTH PETER | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Young Richard A | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise deriv | 2021-03-15 | 2021-03-17 | 3,628 | — | $0 | 90,697 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise | 2021-03-15 | 2021-03-17 | 3,628 | $1.01 | $3.7K | 3,628 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2021-03-15 | 2021-03-17 | 3,628 | $9.47 | $34.4K | 0 | SEC↗ |
| Simonian Nancy A | President & CEO | A Award deriv | 2021-02-17 | 2021-02-19 | 304,000 | — | $0 | 304,000 | SEC↗ |
| Ferra Joseph J Jr | Chief Financial Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 119,000 | — | $0 | 119,000 | SEC↗ |
| Roth David | Chief Medical Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 119,000 | — | $0 | 119,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 94,000 | — | $0 | 94,000 | SEC↗ |
| Quirk Gerald E | Chief Legal & Admin. Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 94,000 | — | $0 | 94,000 | SEC↗ |
| Springhorn Jeremy P. | Chief Business Officer | A Award deriv | 2021-02-17 | 2021-02-19 | 94,000 | — | $0 | 94,000 | SEC↗ |
| Young Richard A | Director | S Sale | 2021-02-16 | 2021-02-18 | 3,750 | $12.05 | $45.2K | 321,711 | SEC↗ |
| Young Richard A | Director | S Sale | 2021-02-08 | 2021-02-10 | 3,750 | $13.04 | $48.9K | 325,461 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise deriv | 2020-12-18 | 2020-12-21 | 10,761 | — | $0 | 21,524 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise deriv | 2020-12-18 | 2020-12-21 | 14,168 | — | $0 | 79,165 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise deriv | 2020-12-18 | 2020-12-21 | 4,988 | — | $0 | 280,012 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise | 2020-12-18 | 2020-12-21 | 10,761 | $3.04 | $32.7K | 544,450 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise | 2020-12-18 | 2020-12-21 | 14,168 | $8.51 | $120.6K | 558,618 | SEC↗ |
| Simonian Nancy A | President & CEO | M Exercise | 2020-12-18 | 2020-12-21 | 4,988 | $10.09 | $50.3K | 563,606 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2020-12-08 | 2020-12-11 | 156,250 | — | $0 | 156,250 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award | 2020-12-08 | 2020-12-11 | 625,000 | — | $0 | 1,899,616 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-11-17 | 2021-02-10 | 5,357 | $8.75 | $46.9K | 329,211 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-11-17 | 2020-11-18 | 5,357 | $8.75 | $46.9K | 339,211 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-11-16 | 2021-02-10 | 633 | $8.98 | $5.7K | 334,568 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-11-16 | 2020-11-18 | 633 | $8.98 | $5.7K | 344,568 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-10-19 | 2020-10-19 | 5,673 | $8.75 | $49.6K | 335,201 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-10-15 | 2020-10-16 | 317 | $8.75 | $2.8K | 340,874 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-09-15 | 2020-09-16 | 5,990 | $10.39 | $62.2K | 341,191 | SEC↗ |
| Eckhardt Sue Gail | Director | A Award deriv | 2020-09-08 | 2020-09-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise deriv | 2020-08-18 | 2020-08-19 | 10,787 | — | $0 | 94,325 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-08-18 | 2020-08-19 | 158,583 | $13.10 | $2.08M | 1,274,616 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise | 2020-08-18 | 2020-08-19 | 10,787 | $1.01 | $10.9K | 10,787 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2020-08-18 | 2020-08-19 | 10,787 | $13.00 | $140.2K | 0 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise deriv | 2020-08-17 | 2020-08-19 | 4,963 | — | $0 | 105,112 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-08-17 | 2020-08-19 | 744 | $13.00 | $9.7K | 1,433,199 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-08-17 | 2020-08-19 | 5,990 | $12.59 | $75.4K | 347,181 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2020-08-17 | 2020-08-19 | 4,963 | $13.00 | $64.5K | 0 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | M Exercise | 2020-08-17 | 2020-08-19 | 4,963 | $1.01 | $5.0K | 4,963 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-07-15 | 2020-07-17 | 5,990 | $11.85 | $71.0K | 353,171 | SEC↗ |
| Olson Eric R | Chief Scientific Officer | S Sale | 2020-07-07 | 2020-07-07 | 1,753 | $11.72 | $20.5K | 0 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-07-01 | 2020-07-06 | 4,627 | $11.01 | $50.9K | 1,433,943 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-06-25 | 2020-06-25 | 54,972 | $11.15 | $612.9K | 1,438,570 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-06-24 | 2020-06-25 | 48,775 | $11.07 | $539.9K | 1,493,542 | SEC↗ |
| AKKARAJU SRINIVAS | Director | S Sale | 2020-06-23 | 2020-06-25 | 50,953 | $11.11 | $566.1K | 1,542,317 | SEC↗ |
| Young Richard A | Director | S Sale | 2020-06-15 | 2020-06-16 | 5,990 | $8.75 | $52.4K | 359,161 | SEC↗ |
| AKKARAJU SRINIVAS | Director | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |